Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Cancer Immunology Research|April 30, 2014
Tumoral immune suppression by macrophages expressing fibroblast activation protein-α and heme oxygenase-1James N Arnold, Lukasz Magiera, Matthew Kraman, et al.Journal of Innate Immunity|April 9, 2010
A new pathway of staphylococcal pathogenesis: apoptosis-like death induced by Staphopain B in human neutrophils and monocytesJan Smagur, Krzysztof Guzik, Lukasz Magiera, et al.Science Translational Medicine|October 30, 2024
Bayesian modeling for analyzing heterogeneous response in preclinical mouse tumor modelsBairu Zhang, Lukasz Magiera, Juliana Candido, et al.Proceedings of the National Academy of Sciences of the United States of America|June 30, 2012
Activation of the Hippo pathway by CTLA-4 regulates the expression of Blimp-1 in the CD8+ T cellJames E D Thaventhiran, Anja Hoffmann, Lukasz Magiera, et al.Science (New York, N.Y.)|November 6, 2010
Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alphaMatthew Kraman, Paul J Bambrough, James N Arnold, et al.Journal for Immunotherapy of Cancer|November 30, 2019
Longitudinal immune characterization of syngeneic tumor models to enable model selection for immune oncology drug discoveryMolly A Taylor, Adina M Hughes, Josephine Walton, et al.Molecular Cancer Therapeutics|August 5, 2022
AZD4625 is a Potent and Selective Inhibitor of KRASG12CAtanu Chakraborty, Lyndsey Hanson, David Robinson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 18, 2020
<i>STAT3</i> Antisense Oligonucleotide Remodels the Suppressive Tumor Microenvironment to Enhance Immune Activation in Combination with Anti-PD-L1Theresa A Proia, Maneesh Singh, Richard Woessner, et al.Journal for Immunotherapy of Cancer|April 7, 2022
Direct targeting of FOXP3 in Tregs with AZD8701, a novel antisense oligonucleotide to relieve immunosuppression in cancerAlexey Revenko, Larissa S Carnevalli, Charles Sinclair, et al.Proceedings of the National Academy of Sciences of the United States of America|October 31, 2020
CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune responseDaniele Biasci, Martin Smoragiewicz, Claire M Connell, et al.Pageof 2